Costantine Albany

3.5k total citations
89 papers, 1.7k citations indexed

About

Costantine Albany is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Costantine Albany has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 34 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Costantine Albany's work include Testicular diseases and treatments (44 papers), Sarcoma Diagnosis and Treatment (21 papers) and Neuroblastoma Research and Treatments (18 papers). Costantine Albany is often cited by papers focused on Testicular diseases and treatments (44 papers), Sarcoma Diagnosis and Treatment (21 papers) and Neuroblastoma Research and Treatments (18 papers). Costantine Albany collaborates with scholars based in United States, Italy and Slovakia. Costantine Albany's co-authors include Lawrence H. Einhorn, Nasser H. Hanna, Nabil Adra, Sandra K. Althouse, Michal Chovanec, Mohammad Abu Zaid, Guru Sonpavde, Mary J. Brames, Rafat Abonour and Natraj Reddy Ammakkanavar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Costantine Albany

87 papers receiving 1.6k citations

Peers

Costantine Albany

SURGE

PRM

ONCOL

NEURO

Michal Chovanec Slovakia

M.A. Kuczyk Germany

Mads Agerbæk Denmark

Gabriella Bernini Italy

Yoshiaki Tsuchida Japan

Yoichi Kameda Japan

Axel Hegele Germany

Salvatore Tumolo Italy

Ricardo Leão Portugal

M. Kuczyk Germany

Michal Chovanec Slovakia

Costantine Albany

965 ×0.9

SURGE

539 ×1.0

PRM

535 ×1.2

508 ×1.4

ONCOL

201 ×0.7

NEURO

Citations per year, relative to Costantine Albany Costantine Albany (= 1×) peers Michal Chovanec

Countries citing papers authored by Costantine Albany

Since Specialization

Citations

This map shows the geographic impact of Costantine Albany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costantine Albany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costantine Albany more than expected).

Fields of papers citing papers by Costantine Albany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costantine Albany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costantine Albany. The network helps show where Costantine Albany may publish in the future.

Co-authorship network of co-authors of Costantine Albany

This figure shows the co-authorship network connecting the top 25 collaborators of Costantine Albany. A scholar is included among the top collaborators of Costantine Albany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costantine Albany. Costantine Albany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daud, Adil, Vamsidhar Velcheti, Katherine M. Bever, et al.. (2024). Efficacy, safety, and PK/PD of LVGN6051, 4-1BB agonistic antibody, with pembrolizumab in a phase Ib dose expansion in resistant NSCLC, melanoma, and GI malignancy.. Journal of Clinical Oncology. 42(16_suppl). 2575–2575.

Spigel, David R., Costantine Albany, Michael Chisamore, et al.. (2023). 753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A849–A849. 1 indexed citations

Sweeney, Christopher J., Ivor Percent, Sunil Babu, et al.. (2022). Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(11). 2237–2247. 31 indexed citations

Albany, Costantine, Travis Dockter, Eric Wolfe, et al.. (2021). Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Supportive Care in Cancer. 29(11). 7129–7130. 1 indexed citations

Feldman, Darren R., Nabil Adra, Mohammad Abu Zaid, et al.. (2021). Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors. Investigational New Drugs. 39(6). 1656–1663. 10 indexed citations

Fazal, Zeeshan, Ratnakar Singh, Fang Fang, et al.. (2020). Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Epigenetics. 16(10). 1071–1084. 30 indexed citations

Beyer, J., Laurence Collette, Gedske Daugaard, et al.. (2020). Prognostic factors in advanced seminoma: An analysis from the IGCCCG Update Consortium.. Journal of Clinical Oncology. 38(6_suppl). 386–386. 9 indexed citations

Schneider, Bryan P., et al.. (2019). Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer. Clinical Genitourinary Cancer. 17(3). 238–239. 3 indexed citations

Albany, Costantine. (2018). Current medical management of patients with poor-risk metastatic germ-cell tumors. Current Opinion in Urology. 28(5). 474–478. 3 indexed citations

10.

Albany, Costantine, Lawrence H. Einhorn, Lawrence Garbo, et al.. (2017). Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases. The Oncologist. 23(3). 316–323. 40 indexed citations

11.

Chovanec, Michal, Maitri Kalra, Noah M. Hahn, et al.. (2017). Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review. Targeted Oncology. 13(1). 49–60. 8 indexed citations

12.

Adra, Nabil, Lawrence H. Einhorn, Sandra K. Althouse, et al.. (2017). Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. Annals of Oncology. 29(1). 209–214. 142 indexed citations

13.

Chovanec, Michal, et al.. (2017). Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma. Clinical Genitourinary Cancer. 15(5). e893–e895. 1 indexed citations

14.

Adra, Nabil, Sandra K. Althouse, Mary J. Brames, et al.. (2016). Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014. Annals of Oncology. 27(5). 875–879. 35 indexed citations

15.

Chovanec, Michal, Nasser H. Hanna, K. Clint Cary, Lawrence H. Einhorn, & Costantine Albany. (2016). Management of stage I testicular germ cell tumours. Nature Reviews Urology. 13(11). 663–673. 45 indexed citations

16.

Galsky, Matthew D., Noah M. Hahn, Bryan Wong, et al.. (2015). Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma. Cancer Chemotherapy and Pharmacology. 76(6). 1259–1265. 6 indexed citations

17.

Albany, Costantine, et al.. (2014). Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature. Journal of Surgical Case Reports. 2014(6). rju051–rju051. 5 indexed citations

18.

Albany, Costantine & Lawrence H. Einhorn. (2013). Extragonadal germ cell tumors. Current Opinion in Oncology. 25(3). 261–265. 79 indexed citations

19.

Albany, Costantine, et al.. (2011). Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. Journal of Medical Case Reports. 5(1). 209–209. 4 indexed citations

20.

Albany, Costantine. (2009). Anti-myelin-associated glycoprotein peripheral neuropathy as the only presentation of low grade lymphoma: a case report. Cases Journal. 2(1). 6370–6370. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact